BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/21/2026 9:00:11 AM | Browse: 5 | Download: 15
 |
Received |
|
2025-12-15 03:44 |
|
Peer-Review Started |
|
2025-12-15 03:44 |
|
First Decision by Editorial Office Director |
|
2025-12-25 08:21 |
|
Return for Revision |
|
2025-12-25 08:21 |
|
Revised |
|
2026-01-05 06:30 |
|
Publication Fee Transferred |
|
2026-01-09 10:22 |
|
Second Decision by Editor |
|
2026-02-11 02:36 |
 |
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2026-02-11 07:01 |
|
Articles in Press |
|
2026-02-11 07:01 |
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2026-04-02 08:04 |
|
Publish the Manuscript Online |
|
2026-04-21 09:00 |
| ISSN |
2218-4333 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2026. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Review |
| Article Title |
Breast cancer and metabolic comorbidities: From epidemiology and molecular mechanisms to precision interventions
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Shen-Hao Zhang, Yang Yang and Yuan Zhang |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yuan Zhang, PhD, Medical College, Yanbian University, No. 977 Gongyuan Road, Yanji 133002, Jilin Province, China. 0000008641@ybu.edu.cn |
| Key Words |
Breast cancer; Metabolic comorbidities; Obesity; Type 2 diabetes mellitus; Precision interventions |
| Core Tip |
Reframes metabolic comorbidities as active, modifiable drivers of breast cancer. Integrates epidemiology, tumour microenvironment, signalling and gut microbiota. Maps obesity, type 2 diabetes mellitus and metabolic syndrome pathways to pharmacologic and lifestyle interventions. Highlights glucagon-like peptide-1 receptor agonists, sodium-glucose cotransporter 2 inhibitors and bariatric surgery as precision tools. Proposes a metabolic oncology model with artificial intelligence-enabled multimodal risk prediction. |
| Publish Date |
2026-04-21 09:00 |
| Citation |
Zhang SH, Yang Y, Zhang Y. Breast cancer and metabolic comorbidities: From epidemiology and molecular mechanisms to precision interventions. World J Clin Oncol 2026; 17(4): 117705 |
| URL |
https://www.wjgnet.com/2218-4333/full/v17/i4/117705.htm |
| DOI |
https://dx.doi.org/10.5306/wjco.v17.i4.117705 |
© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
